SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news

 

 

New EFSA chief commits to, ‘opening up its scientific processes’

1 comment

By Shane Starling+

21-Jul-2014
Last updated on 21-Jul-2014 at 15:49 GMT2014-07-21T15:49:33Z

“In the coming months, input from the public consultation will feed into finalisation of a new Open EFSA policy and follow-up plan.”
“In the coming months, input from the public consultation will feed into finalisation of a new Open EFSA policy and follow-up plan.”

EFSA’s new chief Dr Bernhard Url said greater transparency at the Parma-based agency can boost trust and deliver better opinions.

“EFSA [European Food Safety Authority] is committed to opening up its scientific processes to the widest possible extent and to being more understandable to its partners, stakeholders and the public at large,” Dr Url said last week.

“I believe that not only will this make EFSA more accountable and trusted, but it can also result in more comprehensive, more understandable and better focused scientific advice for decision-makers.”

From various meetings dating back to 2013, the 14-year-old agency noted it has received more than 60 suggestions to improve transparency measures. A summary of those can be found here along with a summary of how the agency seeks to achieve greater transparency, “over the coming years.”

“EFSA wants feedback particularly on these key aspects of the paper and welcomes comments from national partners, other scientific advisory bodies, civil society organisations and other stakeholders as well as experts and practitioners in the field of open government and open science.”

“In the coming months, input from the public consultation will feed into finalisation of a new Open EFSA policy and follow-up plan.”

Transparency limits

Yet the idea of total transparency is not without its opaque edges. Some scientists working on the agency’s various panels have expressed the view that having observers in meetings, for example, would inhibit the scientific debate.  

Professor Sean Strain

Professor Sean Strain of Ulster University, a Panel on Dietetic Products, Nutrition and Allergies (NDA) member, told us recently that observed meetings could inhibit panelists and raised the question of observer influence.

Scientific panels must, "be blind to the needs of the industry and be blind to the needs of the consumer - this is in the remit of the Commission."

Professor Strain added: "I would have sympathy with transparency and open meetings, but I would be totally against recording."

EFSA said examples of greater transparency included public access to documents it was working on as well as making its output, more accessible and understandable.”

1 comment (Comments are now closed)

Openness?

Are you kidding? It would be nice though. Of course, it will never happen, as Politics and big business have nothing to do with openness.

Report abuse

Posted by Laszlo G Meszaros
22 July 2014 | 19h392014-07-22T19:39:51Z

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars